Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof

US6699857B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Jurgen Stoltefuss · Haan, DE
• Gabriele Braunlich · Wuppertal, DE
• Michael Logers · Wuppertal, DE
• Carsten Schmeck · Wuppertal, DE
• Ulrich Nielsch · Wuppertal, DE
• Martin Bechem · Wuppertal, DE
• Christoph Gerdes
• Michael Sperzel · Wuppertal, DE
• Klemens Lustig · Wuppertal, DE
• Werner Stürmer · Stockach, DE

Key dates

• Filing date: Apr 1, 2002
• Grant date: Mar 2, 2004
• Expiry date: Apr 1, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the area of erythropoiesis, in particular to the use of tetrahydroquinolinyl-6-methyldihydrothiadiazinones of general formula (I) for treating anaemia. The invention also relates to novel tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and to the production thereof.